FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称VICASINABIN
异名/同义词(3S)-1-(5-TERT-BUTYL-3-((1-METHYL-1H-TETRAZOL-5-YL)METHYL)-3H-(1,2,3)TRIAZOLO(4,5-D)PYRIMIDIN-7-YL(PYRROLIDIN-3-OL
(S)-1-(5-TERT-BUTYL-3-((1-METHYL-1H-TETRAZOL-5-YL)METHYL)-3H-(1,2,3)TRIAZOLO-(4,5-D)PYRIMIDIN-7-YL)PYRROLIDIN-3-OL
3-PYRROLIDINOL, 1-(5-(1,1-DIMETHYLETHYL)-3-((1-METHYL-1H-TETRAZOL-5-YL)METHYL)-3H-1,2,3-TRIAZOLO(4,5-D)PYRIMIDIN-7-YL)-, (3S)-
RG7774
RG-7774
RO6868847
RO-6868847
VICASINABIN
VICASINABIN [INN]
VICASINABIN [USAN]
CAS登记号1433361-02-4
物质唯一标识(Unique Ingredient Identifier)QJ8UO6C05M
分子式C15H22N10O
国际化合物标识(International Chemical Identifier,InChI)MAYZWDRUFKUGGP-VIFPVBQESA-N
SMILESn1c2c(n(Cc3nnnn3C)n1)nc(C(C)(C)C)nc2N4CC[C@@H](C4)O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System